Skip to main content
PMC home page
Epidemiology and Infection logoLink to Epidemiology and Infection
. 1992 Feb;108(1):1–18. doi: 10.1017/s0950268800049451

Poliomyelitis: eradication in sight.

J L Melnick 1
PMCID: PMC2272176  PMID: 1547830

Full text

PDF
2

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baptista Risi J., Jr The control of poliomyelitis in Brazil. Rev Infect Dis. 1984 May-Jun;6 (Suppl 2):S400–S403. doi: 10.1093/clinids/6.supplement_2.s400. [DOI] [PubMed] [Google Scholar]
  2. Burke K. L., Almond J. W., Evans D. J. Antigen chimeras of poliovirus. Prog Med Virol. 1991;38:56–68. [PubMed] [Google Scholar]
  3. Centers for Disease Control (CDC) Preliminary report: paralytic poliomyelitis--Senegal, 1986. MMWR Morb Mortal Wkly Rep. 1987 Jun 26;36(24):387–390. [PubMed] [Google Scholar]
  4. Centers for Disease Control (CDC) Update: progress toward eradicating poliomyelitis from the Americas. MMWR Morb Mortal Wkly Rep. 1990 Aug 24;39(33):557–561. [PubMed] [Google Scholar]
  5. Chumakov K. M., Powers L. B., Noonan K. E., Roninson I. B., Levenbook I. S. Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptability of oral poliovirus vaccine. Proc Natl Acad Sci U S A. 1991 Jan 1;88(1):199–203. doi: 10.1073/pnas.88.1.199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cockburn W. C. The work of the WHO Consultative Group on Poliomyelitis Vaccines. Bull World Health Organ. 1988;66(2):143–154. [PMC free article] [PubMed] [Google Scholar]
  7. De Quadros C. A., Andrus J. K., Olivé J. M., Da Silveira C. M., Eikhof R. M., Carrasco P., Fitzsimmons J. W., Pinheiro F. P. Eradication of poliomyelitis: progress in the Americas. Pediatr Infect Dis J. 1991 Mar;10(3):222–229. doi: 10.1097/00006454-199103000-00011. [DOI] [PubMed] [Google Scholar]
  8. Eggers H. J. Notes on the pathogenesis of enterovirus infections. Observations, experiments, and speculations. Med Microbiol Immunol. 1990;179(6):297–306. doi: 10.1007/BF00189608. [DOI] [PubMed] [Google Scholar]
  9. Foster S. O., Kesseng-Maben G., N'jie H., Coffi E. Control of poliomyelitis in Africa. Rev Infect Dis. 1984 May-Jun;6 (Suppl 2):S433–S437. doi: 10.1093/clinids/6.supplement_2.s433. [DOI] [PubMed] [Google Scholar]
  10. Goldblum N., Swartz T., Gerichter C. B., Handsher R., Lasch E. E., Melnick J. L. The natural history of poliomyelitis in Israel, 1949-1982. Prog Med Virol. 1984;29:115–123. [PubMed] [Google Scholar]
  11. Henderson R. H., Sundaresan T. Cluster sampling to assess immunization coverage: a review of experience with a simplified sampling method. Bull World Health Organ. 1982;60(2):253–260. [PMC free article] [PubMed] [Google Scholar]
  12. Heymann D. L., Floyd V. D., Lichnevski M., Maben G. K., Mvongo F. Estimation of incidence of poliomyelitis by three survey methods in different regions of the United Republic of Cameroon. Bull World Health Organ. 1983;61(3):501–507. [PMC free article] [PubMed] [Google Scholar]
  13. Heymann D. L., Murphy K., Brigaud M., Aymard M., Tembon A., Maben G. K. Oral poliovirus vaccine in tropical Africa: greater impact on incidence of paralytic disease than expected from coverage surveys and seroconversion rates. Bull World Health Organ. 1987;65(4):495–501. [PMC free article] [PubMed] [Google Scholar]
  14. Hogle J. M., Chow M., Filman D. J. Three-dimensional structure of poliovirus at 2.9 A resolution. Science. 1985 Sep 27;229(4720):1358–1365. doi: 10.1126/science.2994218. [DOI] [PubMed] [Google Scholar]
  15. Hovi T., Cantell K., Huovilainen A., Kinnunen E., Kuronen T., Lapinleimu K., Pöyry T., Roivainen M., Salama N., Stenvik M. Outbreak of paralytic poliomyelitis in Finland: widespread circulation of antigenically altered poliovirus type 3 in a vaccinated population. Lancet. 1986 Jun 21;1(8495):1427–1432. doi: 10.1016/s0140-6736(86)91566-7. [DOI] [PubMed] [Google Scholar]
  16. John T. J. Poliomyelitis in India: prospects and problems of control. Rev Infect Dis. 1984 May-Jun;6 (Suppl 2):S438–S441. doi: 10.1093/clinids/6.supplement_2.s438. [DOI] [PubMed] [Google Scholar]
  17. Koike S., Taya C., Kurata T., Abe S., Ise I., Yonekawa H., Nomoto A. Transgenic mice susceptible to poliovirus. Proc Natl Acad Sci U S A. 1991 Feb 1;88(3):951–955. doi: 10.1073/pnas.88.3.951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. LaForce F. M., Lichnevski M. S., Keja J., Henderson R. H. Clinical survey techniques to estimate prevalence and annual incidence of poliomyelitis in developing countries. Bull World Health Organ. 1980;58(4):609–620. [PMC free article] [PubMed] [Google Scholar]
  19. Lasch E. E., Abed Y., Abdulla K., El Tibbi A. G., Marcus O., El Massri M., Handscher R., Gerichter C. B., Melnick J. L. Successful results of a program combining live and inactivated poliovirus vaccines to control poliomyelitis in Gaza. Rev Infect Dis. 1984 May-Jun;6 (Suppl 2):S467–S470. doi: 10.1093/clinids/6.supplement_2.s467. [DOI] [PubMed] [Google Scholar]
  20. Lasch E. E., Abed Y., Marcus O., Gerichter C. B., Melnick J. L. Combined live and inactivated poliovirus vaccine to control poliomyelitis in a developing country--five years after. Dev Biol Stand. 1986;65:137–143. [PubMed] [Google Scholar]
  21. MELNICK J. L., ASHKENAZI A., MIDULLA V. C., WALLIS C., BERNSTEIN A. Immunogenic potency of magnesium chloride-stabilized oral poliovaccine. JAMA. 1963 Aug 3;185:406–408. doi: 10.1001/jama.1963.03060050084032. [DOI] [PubMed] [Google Scholar]
  22. McBean A. M., Thoms M. L., Albrecht P., Cuthie J. C., Bernier R. Serologic response to oral polio vaccine and enhanced-potency inactivated polio vaccines. Am J Epidemiol. 1988 Sep;128(3):615–628. doi: 10.1093/oxfordjournals.aje.a115009. [DOI] [PubMed] [Google Scholar]
  23. Melnick J. L. Advantages and disadvantages of killed and live poliomyelitis vaccines. Bull World Health Organ. 1978;56(1):21–38. [PMC free article] [PubMed] [Google Scholar]
  24. Melnick J. L. Combined use of live and killed vaccines to control poliomyelitis in tropical areas. Dev Biol Stand. 1981;47:265–273. [PubMed] [Google Scholar]
  25. Minor P. D., Ferguson M., Evans D. M., Almond J. W., Icenogle J. P. Antigenic structure of polioviruses of serotypes 1, 2 and 3. J Gen Virol. 1986 Jul;67(Pt 7):1283–1291. doi: 10.1099/0022-1317-67-7-1283. [DOI] [PubMed] [Google Scholar]
  26. Mirchamsy H., Shafyi A., Mahinpour M., Nazari P. Stabilizing effect of magnesium chloride and sucrose on Sabin live polio vaccine. Dev Biol Stand. 1978;41:255–257. [PubMed] [Google Scholar]
  27. Morrison L. A., Fields B. N. Parallel mechanisms in neuropathogenesis of enteric virus infections. J Virol. 1991 Jun;65(6):2767–2772. doi: 10.1128/jvi.65.6.2767-2772.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Nkowane B. M., Wassilak S. G., Orenstein W. A., Bart K. J., Schonberger L. B., Hinman A. R., Kew O. M. Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984. JAMA. 1987 Mar 13;257(10):1335–1340. [PubMed] [Google Scholar]
  29. Ofosu-Amaah S., Kratzer J. H., Nicholas D. D. Is poliomyelitis a serious problem in developing countries?--lameness in Ghanaian schools. Br Med J. 1977 Apr 16;1(6067):1012–1014. doi: 10.1136/bmj.1.6067.1012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Ogra P. L., Faden H. S., Abraham R., Duffy L. C., Sun M., Minor P. D. Effect of prior immunity on the shedding of virulent revertant virus in feces after oral immunization with live attenuated poliovirus vaccines. J Infect Dis. 1991 Jul;164(1):191–194. doi: 10.1093/infdis/164.1.191. [DOI] [PubMed] [Google Scholar]
  31. Patriarca P. A., Laender F., Palmeira G., Oliveira M. J., Lima Filho J., Dantes M. C., Cordeiro M. T., Risi J. B., Jr, Orenstein W. A. Randomised trial of alternative formulations of oral poliovaccine in Brazil. Lancet. 1988 Feb 27;1(8583):429–433. doi: 10.1016/s0140-6736(88)91229-9. [DOI] [PubMed] [Google Scholar]
  32. Ren R. B., Costantini F., Gorgacz E. J., Lee J. J., Racaniello V. R. Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis. Cell. 1990 Oct 19;63(2):353–362. doi: 10.1016/0092-8674(90)90168-e. [DOI] [PubMed] [Google Scholar]
  33. Robinson D. A. Polio vaccination--a review of strategies. Trans R Soc Trop Med Hyg. 1982;76(5):575–581. doi: 10.1016/0035-9203(82)90214-0. [DOI] [PubMed] [Google Scholar]
  34. Rotbart H. A. New methods of rapid enteroviral diagnosis. Prog Med Virol. 1991;38:96–108. [PubMed] [Google Scholar]
  35. Sabin A. B. Oral poliovirus vaccine: history of its development and use and current challenge to eliminate poliomyelitis from the world. J Infect Dis. 1985 Mar;151(3):420–436. doi: 10.1093/infdis/151.3.420. [DOI] [PubMed] [Google Scholar]
  36. Sabin A. B. Paralytic poliomyelitis: Old dogmas and new perspectives. Rev Infect Dis. 1981 May-Jun;3(3):543–564. doi: 10.1093/clinids/3.3.543. [DOI] [PubMed] [Google Scholar]
  37. Schaap G. J., Bijkerk H., Coutinho R. A., Kapsenberg J. G., van Wezel A. L. The spread of wild poliovirus in the well-vaccinated Netherlands in connection with the 1978 epidemic. Prog Med Virol. 1984;29:124–140. [PubMed] [Google Scholar]
  38. Slater P. E., Orenstein W. A., Morag A., Avni A., Handsher R., Green M. S., Costin C., Yarrow A., Rishpon S., Havkin O. Poliomyelitis outbreak in Israel in 1988: a report with two commentaries. Lancet. 1990 May 19;335(8699):1192–1198. doi: 10.1016/0140-6736(90)92705-m. [DOI] [PubMed] [Google Scholar]
  39. Stoeckel P., Schlumberger M., Parent G., Maire B., van Wezel A., van Steenis G., Evans A., Salk D. Use of killed poliovirus vaccine in a routine immunization program in West Africa. Rev Infect Dis. 1984 May-Jun;6 (Suppl 2):S463–S466. doi: 10.1093/clinids/6.supplement_2.s463. [DOI] [PubMed] [Google Scholar]
  40. Tulchinsky T., Abed Y., Shaheen S., Toubassi N., Sever Y., Schoenbaum M., Handsher R. A ten-year experience in control of poliomyelitis through a combination of live and killed vaccines in two developing areas. Am J Public Health. 1989 Dec;79(12):1648–1652. doi: 10.2105/ajph.79.12.1648. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. da Silva E. E., Pallansch M. A., Holloway B. P., Oliveira M. J., Schatzmayr H. G., Kew O. M. Oligonucleotide probes for the specific detection of the wild poliovirus types 1 and 3 endemic to Brazil. Intervirology. 1991;32(3):149–159. doi: 10.1159/000150195. [DOI] [PubMed] [Google Scholar]
  42. von Magnus H., Petersen I. Vaccination with inactivated poliovirus vaccine and oral poliovirus vaccine in Denmark. Rev Infect Dis. 1984 May-Jun;6 (Suppl 2):S471–S474. doi: 10.1093/clinids/6.supplement_2.s471. [DOI] [PubMed] [Google Scholar]

Articles from Epidemiology and Infection are provided here courtesy of Cambridge University Press

RESOURCES